Efficacy of fimaSartan on arTerIal stiFFness iN patiEntS With HypertenSion
NCT02022774 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2023-07-06
Summary
The purpose of this study is to evaluate the effects of fimasartan on arterial stiffness in patients with hypertension
Conditions
Interventions
- DRUG
-
Fimasartan
Fimasartan 60 \~ 120 mg/po take one tablet once a day
Sponsors & Collaborators
-
Boryung Pharmaceutical Co., Ltd
lead INDUSTRY
Principal Investigators
-
Kye Hun Kim, MD · Chonnam National University Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2017-06-30
- Completion
- 2017-06-30
Countries
- South Korea
Study Locations
More Related Trials
-
Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension Patients
NCT00923611 ·Status: COMPLETED ·Phase: PHASE2
-
A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension
NCT00922441 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan
NCT02620306 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male Volunteers
NCT00937534 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy
NCT01258673 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety and Pharmacodynamic/Pharmacokinetic Study of Fimasartan (BR-A-657•K)
NCT00937651 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of High- and Low-sodium Intake on the Pharmacokinetics and Pharmacodynamic Effects of Fimasartan
NCT02147704 ·Status: COMPLETED ·Phase: PHASE4
-
Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects
NCT01289886 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers
NCT01146938 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of BR1015 Combination Therapy
NCT05878561 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male Volunteers
NCT00938132 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial of Fimasartan for Early Diastolic Heart Failure
NCT01691118 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial to Evaluate Pharmacokinetic Interactions and Safety Between Fimasartan and Linagliptin in Healthy Male Volunteers
NCT03250052 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide
NCT02222480 ·Status: COMPLETED ·Phase: PHASE2
-
Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects
NCT01289899 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Renal Impairment Patients and Healthy Volunteers
NCT01148368 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Characteristics and Medication Satisfaction of Kanarb Tablet in Korean Hypertensive Patient(Kanarb-Hypertension Epidemiology Medication Satisfaction Study)
NCT02394392 ·Status: COMPLETED
-
Effect of Fimasartan on Extended RAS and Vascular Functions in Patients With Type 2 Diabetes and Hypertension
NCT05173025 ·Status: UNKNOWN ·Phase: PHASE4
-
Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECG
NCT03219632 ·Status: COMPLETED
-
Post-Authorization Long-term Safety Surveillance on Antihypertensive Treatment With Kanarb® (Fimasartan)
NCT02385721 ·Status: COMPLETED
-
Clinical Study to Evaluate the Antihypertensive Efficacy and Changes of Neurohormonal Markers of Fimasartan and Atenolol With Exaggerated Blood Pressure Response During Exercise in Essential Hypertensive Patients
NCT01736488 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacovigilance and Patient Compliance in Hypertensive Patients
NCT02200575 ·Status: COMPLETED
-
Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential Hypertension
NCT02466490 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan) and Cozaar® (Losartan) in Adult Patients With Grade I-II Arterial Hypertension
NCT02248961 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential Hypertension
NCT02407210 ·Status: UNKNOWN ·Phase: PHASE3